Sandoz to Aquire GSK’s Cephalosporin Antibiotics
Sandoz, the generics division of Swiss drugmaker Novartis, is picking up GlaxoSmithKline’s cephalosporin antibiotics business, including the brands Zinnat, Zinacef and Fortum, for up to $500 million.
News
The IIoT Needs You and Me
The IIoT continues to evolve, with countless solutions touting end-to-end process automation. However, one of the most important elements of IIoT — the human element — has taken a back burner in this hype cycle.
Regis Technologies Completes Lab Expansion
US-based CDMO Regis Technologies has completed a major expansion of its laboratory facilities for development of active pharmaceutical ingredients (APIs) at its site in Morton Grove, Illinois. The project, kicked off two years ago, doubles the company’s capacity to take on new development projects.
AbbVie and Caribou in CAR-T Collaboration
US biopharma AbbVie and compatriot biotech Caribou Biosciences have entered into a multi-year collaboration and license agreement to research and develop chimeric antigen receptor (CAR)-T cell therapeutics.
Repsol Licenses Technologies to China
Spanish energy and petrochemical group Repsol has signed a licensing agreement for its propylene oxide/styrene monomer (PO/SM) and polyols technologies for three plants in China.
PolyPeptide Group Appoints Raymond De Vré as new CEO
PolyPeptide Group has appointed Raymond De Vré as its new Chief Executive Officer (CEO). He will succeed Jane Salik who, after 15 years in this position, will concentrate on her role on the Board of Directors.
Chemours Splits Fluoroproducts Division
US chemical company Chemours announced on Feb. 11 that it had split its Fluoroproducts segment into two distinct businesses during the fourth quarter of 2020.
WHO Grants EUA for AstraZeneca Vaccine
The World Health Organization (WHO) has granted emergency use authorization (EUA) to the AstraZeneca/ Oxford University coronavirus vaccine, in an attempt to distribute doses to more Third World countries. The vaccine will be produced by the Serum Institute of India and AstraZeneca-SKBio of South Korea.
J&J Applies to EMA for Covid Vaccine Approval
As had been awaited, US healthcare giant Johnson & Johnson has applied to the European Medicines Authority (EMA) for conditional marketing authorization of its Covid-19 coronavirus vaccine throughout the EU.
Elkem Buys French Silicones Plant
Elkem, a Norwegian manufacturer of silicon-based advanced materials, has agreed to buy a brand-new production plant near Lyon in France. The identity of the seller was not disclosed but Elkem said the purchase price is in the low double-digit millions of euros.
Rentschler Invests in UK Cell and Gene Therapy Site
German CDMO Rentschler Biopharma is to establish manufacturing capacity for advanced therapy medicinal products (ATMPs), including Adeno-associated virus (AAV) vectors for clinical trials, at the Cell and Gene Therapy Catapult (CGT) site in Stevenage, UK.
Germany's Merck Invests €18 million in Arizona Site
Germany’s Merck is investing €18 million at its new site in Tempe, Arizona, USA, including the purchase of the 28,000 m2 production facility leased by previous owner Versum Materials, a business it acquired In 2019.
Shell Invests in Chemicals to Accelerate Zero Emissions Goal
Shell has announced plans to invest $4-5 billion annually to grow its chemicals and products business as part of an organizational restructuring that aims to accelerate the Anglo-Dutch group’s target of becoming a net-zero emissions energy business by 2050 or sooner.
CureVac Vaccine in EMA Rolling Review Process
German biotech CureVac has begun a rolling submission with the European Medicines Agency (EMA) for its mRNA-based Covid-19 vaccine candidate currently in Phase 2b/3 clinical trials with 35,000 people in Europe and Latin America.
Lanxess to Acquire Emerald Kalama Chemical
Germany’s Lanxess has signed a binding agreement to acquire 100% of Emerald Kalama Chemical from affiliates of private equity firm American Securities. The US specialty chemicals producer focused mainly on consumer markets last reported sales of $425 million and EBITDA pre-exceptionals of $90 million. Closing is expected in the second half of 2021, subject to regulatory approval.
BioNTech Starts mRNA Production in Marburg
BioNTech this week kicked off production at the Marburg, Germany, plant it acquired last year from Novartis. The plant will focus on making mRNA batches, the beginning of the manufacturing chain for the Covid-19 vaccine Comirnaty that BioNTech is producing and marketing together with US drugmaker Pfizer.
Honeywell Wins Egyptian Petchems Contract
Honeywell Process Solutions (HPS) has won a contract to upgrade Sidi Kerir Petrochemicals Company’s (Sidpec) production capabilities at its flagship complex in Alexandria, Egypt.
FDA Grants EUA for Lilly Antibody Cocktail
The US Food and Drug administration (FDA) has granted an Emergency Use Authorization (EUA) for the bamlanivimab-etesevimab antibody cocktail made by Eli Lilly for treatment of patients 12 and older who have mild to moderate cases of Covid-19 but are at risk of developing a severe form of the disease.
Ercros Launches Three-Dimensional Sustainability Strategy
Spanish chemical company Ercros has launched a three-year strategic plan to improve its sustainability. The plan, which incorporates 20 projects, is based on three dimensions: diversification, digitalization and decarbonization.
China’s WuXi Buys Bristol Myers Squibb’s Swiss Plant
China contract development and manufacturing organization (CDMO) WuXi STA has agreed to buy Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland, for an undisclosed sum. The site will be WuXi STA’s first facility in Europe. The transaction is expected to complete during the second quarter, subject to the usual conditions and regulatory approvals.
Clariant Finances Catalyst Research at ETH Zurich
Clariant has signed a cooperation agreement with the Swiss Federal Institute of Technology (ETH Zurich) to support research in catalysis and sustainable chemistry. It is providing the university with what it says is “a significant financial contribution” over an initial period of ten years. Terms were not disclosed.
Jazz Buys the UK’s GW Pharma
Ireland-based multinational drug company Jazz Pharmaceuticals is to buy UK biopharma GW Pharma for $7.2 billion, creating a leader in neuroscience. The boards of directors of both companies have unanimously approved the deal, which is expected to close in the second quarter, subject to customary conditions and regulatory approvals.
Pfizer and BionTech Aim to Cut Vaccine Production Time
Pfizer and BioNTech are accelerating the time it takes to produce a Covid-19 vaccine batch and are aiming to almost cut it in half, Chaz Calitri, vice president of sterile injectables at Pfizer, said in an interview with the US newspaper USA Today.
Nuberg Wins Egypt Sulfuric Acid Project
Indian engineering group Nuberg has been awarded a sulfuric acid project in Egypt. Chemicals and plastics manufacturer Sprea Misr has granted a lumpsum turnkey contract for the project’s engineering, procurement and construction services. The value of the contract was not disclosed.
Borealis Kicks off Sales Process for Nitrogen
Austrian chemical producer Borealis has announced plans to divest its nitrogen business, including fertilizer, technical nitrogen and melamine products. The Vienna-based group, which has increasingly shifted its focus to petrochemicals and plastics, has begun consultations with employee representatives.
AkzoNobel Walks Away from Tikkurila
AkzoNobel has conceded defeat in its bid to buy Tikkurila, leaving the way clear for US rival PPG Industries to continue with its acquisition of the Finnish paints and coatings company.
Archroma and CleanKore Collaborate on Denim Dyeing
Swiss specialty chemicals company Archroma is partnering US firm CleanKore to advance sustainable dyeing processes for producing clothes made from denim.
Germany’s Merck to Expand Lipid Supply to BioNTech
Expanding its supply relationship with compatriot BioNTech, Germany’s Merck said it will “significantly accelerate” the supply of urgently needed lipids to vaccine maker BionTech at Mainz and increase the volume of deliveries up to the end of 2021.
Wacker Chemie to Buy California CDMO Genopis
German chemical producer Wacker Chemie is acquiring 100% of San Diego, California- headquartered CDMO Genopis from its two South Korean owners, Helixmith and Medivate Partner, both based in Seoul.
India’s Eternis Acquires Tennants Fine Chemicals
Indian aroma chemicals producer Eternis has acquired the UK’s Tennants Fine Chemicals and its wholly owned subsidiaries in Singapore and Shanghai, China, for an undisclosed sum. The deal is Eternis’ first acquisition outside of India.
BASF again Named World’s Most Valuable Chemicals Brand
A coalescing of factors has led to arrested growth across the chemicals sector this year, with the brand value of the top 25 most valuable chemicals brands contracting by 8% on average, according to the latest report by Brand Finance, an independent brand valuation consultancy.
Novozymes and FMC Link on Biological Pest Control
Danish biotech Novozymes has announced a collaboration with US agricultural sciences group FMC to research, develop and commercialize biological enzyme-based crop protection solutions. The move is part of Novozymes’ entry into the biocontrol segment, using its new enzyme-based technology.
BASF Commissions Custom Rhine Tanker
To facilitate shipping on the Rhine River at extremely low water levels, BASF has commissioned a special tanker, which is currently being built by Stolt Tankers. Scheduled for delivery in late 2022, it will be operated exclusively for the German chemical group.
Azelis Takes Over Italy’s Came
Continuing its acquisition spree of recent weeks, Azelis is to take over Italy’s Came Chemical Mineral and Engineering for an undisclosed sum. Headquartered in Milan, Came specializes in distributing chemicals for friction and sintering applications, the coatings, adhesives, sealants and elastomers (CASE) segment and cosmetics.
DuPont Sells Clean Technologies to Consortium
DuPont has agreed to sell its Clean Technologies business for $510 million to an international private equity consortium, comprising BroadPeak Global, Asia Green Fund and The Saudi Arabian Industrial Investments Company (Dussur).
